Pathfinder Cell Therapy, Inc. (PFND)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2014 2013 2012 2011 2010 2009
Revenue - 54 Thousand 114 Thousand 73 Thousand 344 Thousand 360 Thousand
Cost of Revenue - 37 Thousand 50 Thousand 26 Thousand 92 Thousand 164 Thousand
Gross Profit - 17 Thousand 64 Thousand 47 Thousand 252 Thousand 196 Thousand
Operating Expenses 1.11 Million 1.61 Million 2.12 Million 3.66 Million 2.75 Million 4.31 Million
Selling, General and Administrative Expenses 857 Thousand 944 Thousand 796 Thousand 1.98 Million 2.02 Million 2.92 Million
Research and Development Expenses 262 Thousand 672 Thousand 1.32 Million 1.67 Million 728 Thousand 1.38 Million
Other Expenses - - - - - -
Cost and Expenses 1.11 Million 1.65 Million 2.17 Million 3.69 Million 2.84 Million 4.48 Million
Operating Income -1.11 Million -1.59 Million -2.06 Million 3.92 Million -2.49 Million -4.12 Million
Interest Expense - - 96 Thousand 108 Thousand 12 Thousand 3000.00
Income Tax Expense 275 Thousand 106 Thousand 96 Thousand 7.65 Million -433 Thousand 20 Thousand
Earnings before Tax -1.39 Million -1.7 Million -2.15 Million -11.27 Million -2.5 Million -4.1 Million
Net Income -1.66 Million -1.81 Million -2.25 Million -18.92 Million -2.07 Million -4.1 Million
Earnings Per Share Basic -0.00 -0.00 -0.00 -0.04 -0.00 -0.04
Earnings Per Share Diluted -0.00 -0.00 -0.00 -0.04 -0.00 -0.04
Weighted Average Shares Outstanding 667.16 Million 667.16 Million 667.16 Million 526.1 Million 457.99 Million 100.92 Million
Weighted Average Shares Outstanding (Diluted) 667.16 Million 667.16 Million 667.16 Million 526.1 Million 457.99 Million 100.92 Million
Gross Margin - 0.31 0.56 0.64 0.73 0.54
EBIT Margin - -31.06 -17.89 54.04 -7.23 -11.26
Profit Margin - -33.54 -19.75 -259.21 -6.03 -11.40
EBITDA -1.11 Million -1.58 Million -2.04 Million -3.59 Million -2.48 Million -4.05 Million
Earnings Before Tax Margin - -29.61 -18.07 53.78 -7.26 -11.44

Income Statement Charts